Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancer
Bonnita Werner(UNSW Sydney), Caroline E. Ford(UNSW Sydney), Sivatharsny Srirangan(Westmead Institute for Medical Research), Pamela Provan(The University of Sydney), Vivek Arora(Royal Hospital for Women), Kristina Warton(UNSW Sydney), Yeh Chen Lee(Royal Hospital for Women), Nicole Laurencia Yuwono(UNSW Sydney), Dongli Liu(Unknown), Catherine David(Royal Hospital for Women), Rhonda Farrell(Prince of Wales Hospital), Jennifer Duggan(Royal Hospital for Women), Anna DeFazio(The University of Sydney)
Cited by 42
Related Papers
Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
|Clinical Cancer Research|2008|1.5k
<i>BRCA</i> Mutation Frequency and Patterns of Treatment Response in <i>BRCA</i> Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
|Journal of Clinical Oncology|2012|1.2k
Driver mutations in <i>TP53</i> are ubiquitous in high grade serous carcinoma of the ovary
|The Journal of Pathology|2010|836
Mutation of <i>FOXL2</i> in Granulosa-Cell Tumors of the Ovary
|New England Journal of Medicine|2009|775